Century Therapeutics, Inc. – NASDAQ:IPSC
Century Therapeutics stock price today
$0.56
-0.48
-46.15%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
Century Therapeutics stock price monthly change
-65.10%
month
Century Therapeutics stock price quarterly change
-65.10%
quarter
Century Therapeutics stock price yearly change
-65.79%
year
Century Therapeutics key metrics
Market Cap | 88.43M |
Enterprise value | 147.65M |
P/E | -1.45 |
EV/Sales | 28.40 |
EV/EBITDA | -1.21 |
Price/Sales | 35.10 |
Price/Book | 0.60 |
PEG ratio | -0.06 |
EPS | -2.22 |
Revenue | 1.37M |
EBITDA | -108.02M |
Income | -133.47M |
Revenue Q/Q | -50.29% |
Revenue Y/Y | -76.62% |
Profit margin | -2518.41% |
Oper. margin | -2574.17% |
Gross margin | 0% |
EBIT margin | -2574.17% |
EBITDA margin | -7885.18% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCentury Therapeutics stock price history
Century Therapeutics stock forecast
Century Therapeutics financial statements
Average Price Target
$5
Potential upside: 792.85%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 99K | -33.29M | -33627.27% |
|---|---|---|---|
| Sep 2023 | 148K | -32.72M | -22108.11% |
| Dec 2023 | 268K | -39.39M | -14700.75% |
| Mar 2024 | 855K | -28.06M | -3282.11% |
| 2023-11-09 | -0.53 | -0.55 |
|---|---|---|
| 2024-03-14 | -0.56 | -0.49 |
| 2024-05-09 | -0.5 | -0.45 |
| Jun 2023 | 417159000 | 169.58M | 40.65% |
|---|---|---|---|
| Sep 2023 | 397551000 | 178.32M | 44.85% |
| Dec 2023 | 360691000 | 175.94M | 48.78% |
| Mar 2024 | 348507000 | 170.62M | 48.96% |
| Jun 2023 | -19.25M | 6.97M | -10.11M |
|---|---|---|---|
| Sep 2023 | -13.64M | 4.21M | 300K |
| Dec 2023 | -26.23M | 18.60M | -356K |
| Mar 2024 | -30.24M | 11.54M | 18.19M |
Century Therapeutics alternative data
| Aug 2023 | 163 |
|---|---|
| Sep 2023 | 163 |
| Oct 2023 | 163 |
| Nov 2023 | 163 |
| Dec 2023 | 163 |
| Jan 2024 | 163 |
| Feb 2024 | 163 |
| Mar 2024 | 152 |
| Apr 2024 | 152 |
| May 2024 | 152 |
| Jun 2024 | 152 |
| Jul 2024 | 152 |
Century Therapeutics other data
15.58%
-20.45%
of IPSC is owned by hedge funds
33
-32
9.00M
-11.89M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 5504 |
| Mar 2024 | 0 | 53515 |
| Apr 2024 | 0 | 5000 |
| May 2024 | 0 | 11170 |
| Jun 2024 | 0 | 10000 |
| Jul 2024 | 0 | 2386 |
| Aug 2024 | 0 | 1362 |
| Sep 2024 | 5000 | 0 |
| Nov 2024 | 0 | 1316 |
-
What's the price of Century Therapeutics stock today?
One share of Century Therapeutics stock can currently be purchased for approximately $0.56.
-
When is Century Therapeutics's next earnings date?
Unfortunately, Century Therapeutics's (IPSC) next earnings date is currently unknown.
-
Does Century Therapeutics pay dividends?
No, Century Therapeutics does not pay dividends.
-
How much money does Century Therapeutics make?
Century Therapeutics has a market capitalization of 88.43M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 57.01% to 2.24M US dollars. Century Therapeutics made a loss 136.67M US dollars in net income (profit) last year or -$0.45 on an earnings per share basis.
-
What is Century Therapeutics's stock symbol?
Century Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "IPSC".
-
What is Century Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Century Therapeutics?
Shares of Century Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Century Therapeutics have?
As Jul 2024, Century Therapeutics employs 152 workers.
-
When Century Therapeutics went public?
Century Therapeutics, Inc. is publicly traded company for more then 4 years since IPO on 18 Jun 2021.
-
What is Century Therapeutics's official website?
The official website for Century Therapeutics is centurytx.com.
-
Where are Century Therapeutics's headquarters?
Century Therapeutics is headquartered at 3675 Market Street, Philadelphia, PA.
-
How can i contact Century Therapeutics?
Century Therapeutics's mailing address is 3675 Market Street, Philadelphia, PA and company can be reached via phone at +267 8175790.
-
What is Century Therapeutics stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Century Therapeutics in the last 12 months, the avarage price target is $5. The average price target represents a 792.85% change from the last price of $0.56.
Century Therapeutics company profile:
Century Therapeutics, Inc.
centurytx.comExchange:
NASDAQ
Full time employees:
152
Industry:
Biotechnology
Sector:
Healthcare
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
3675 Market Street
Philadelphia, PA 19104
Philadelphia, PA 19104
CIK: 0001850119
ISIN: US15673T1007
CUSIP: 15673T100
